Back

A platform for assessing pro- and anti-arrhythmic effects of drugs based on isogenic human iPSC-derived cardiomyocytes

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - 43rd EWGCCE Meeting Arrhythmias EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Giulia Campostrini

Leiden University Medical Center, Leiden (Netherlands (The))

17 More presentations in this session

Presentation thumbnail
The hidden electrophysiological cardiotoxic effects of rofecoxib are prevented by ischaemic preconditioning
Doctor Z. Husti (Szeged, HU)
Abstract
Presentation thumbnail
A high-throughput system to reliably characterize normal human ventricular electrophysiology from living patients
Doctor A. Olivan-Viguera (Zaragoza, ES)
Abstract
Presentation thumbnail
Pros and cons of human iPSC cardiomyocytes in drug testing and disease modelling: insights from computational modelling
Doctor J. Koivumaeki (Tampere, FI)
Abstract
Presentation thumbnail
Advanced morpho-functional analysis on ventricular and atrial tissue reveals sarcomere energetic impairment in hcm patients
Miss E. Lazzeri (Florence, IT)
Abstract
Presentation thumbnail
Istaroxime improves diabetic diastolic dysfunction through SERCA stimulation

Access the full session

Session thumbnail
Poster Session 1 - 43rd EWGCCE Meeting

The Event

Event poster

EHRA 2019

17 March - 19 March 2019
You may be interested in
thumbnail
Congress Session
Risk stratification
thumbnail
Congress Presentation
Anatomical correlates of VF ablation 
thumbnail
Congress Session
Malignant arrhythmias

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources